Researchers studied the calcium antagonist nifedipine, a drug used to treat angina, and found it to be safe and effective for long-term use. The study, published in the Lancet, included more than 3800 patients taking nifedipine and another 3800 patients taking placebo. Results at 5 years showed similar mortality rates for both groups and lower incidence of heart failure and coronary incidents among patients in the nifedipine group. While some research had previously questioned the safety of nifedipine for long-term use, this study proves it can be used safely among patients with coronary disease and angina.
In Seniors: Consider CMV Serostatus
When Recommending Flu Vaccine
Older people who have cytomegalovirus seem to have less robust responses to the trivalent influenza vaccine than those who do not have CMV.
News from the year's biggest meetings
Clinical features with downloadable PDFs